Traumatic brain injury (TBI) affects persons of all ages and is recognized as a major cause of death and disability worldwide; it also brings heavy life burden to patients and their families. The treatment of those with secondary injury after TBI is still scarce, however. Alternative splicing (AS) is a crucial post-transcriptional regulatory mechanism associated with various physiological processes, while the contribution of AS in treatment after TBI is poorly illuminated. In this study, we performed and analyzed the transcriptome and proteome datasets of brain tissue at multiple time points in a controlled cortical impact (CCI) mouse model. We found that AS, as an independent change against the transcriptional level, is a novel mechanism linked to cerebral edema after TBI. Bioinformatics analysis further indicated that the transformation of splicing isoforms after TBI was related to cerebral edema. Accordingly, we found that the fourth exon of transient receptor potential channel melastatin 4 (Trpm4) abrogated skipping at 72 h after TBI, resulting in a frameshift of the encoded amino acid and an increase in the proportion of spliced isoforms. Using magnetic resonance imaging (MRI), we have shown the numbers of 3nEx isoforms of Trpm4 may be positively correlated with volume of cerebral edema. Thus alternative splicing of Trpm4 becomes a noteworthy mechanism of potential influence on edema. In summary, alternative splicing of Trpm4 may drive cerebral edema after TBI. Trpm4 is a potential therapeutic targeting cerebral edema in patients with TBI.
Get full access to this article
View all access options for this article.
References
1.
GalganoM, ToshkeziG, QiuX, et al.Traumatic brain injury: current treatment strategies and future endeavors. Cell Transplant, 2017; 26(7):1118–1130; doi:10.1177/0963689717714102
2.
ThraneAS, Rangroo ThraneV, NedergaardM. Drowning stars: reassessing the role of astrocytes in brain edema. Trends Neurosci, 2014; 37(11):620–628; doi:10.1016/j.tins.2014.08.010
3.
HammondTR, DufortC, Dissing-OlesenL, et al.Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity, 2019; 50(1):253–271.e6; doi:10.1016/j.immuni.2018.11.004
4.
PanQ, ShaiO, LeeLJ, et al.Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature Genetics, 2008; 40(12):1413–1415; doi:10.1038/ng.259
5.
SultanM, SchulzMH, RichardH, et al.A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science, 2008; 321(5891):956–960; doi:10.1126/science.1160342
6.
GongL, WuJ, ZhouS, et al.Global analysis of transcriptome in dorsal root ganglia following peripheral nerve injury in rats. Biochem Biophys Res Commun, 2016; 478(1):206–212; doi:10.1016/j.bbrc.2016.07.067
7.
BlackDL. Mechanisms of alternative pre-messenger RNA splicing. Ann Rev Biochem, 2003; 72:291–336; doi:10.1146/annurev.biochem.72.121801.161720
8.
YapK, MakeyevEV. Regulation of gene expression in mammalian nervous system through alternative pre-mRNA splicing coupled with RNA quality control mechanisms. Molecular and cellular neurosciences, 2013; 56:420–428; doi:10.1016/j.mcn.2013.01.003
HinkleER, WiednerHJ, BlackAJ, et al.RNA processing in skeletal muscle biology and disease. Transcription, 2019; 10(1):1–20; doi:10.1080/21541264.2018.1558677
11.
JacksonTC, KochanekPM. RNA Binding Motif 5 (RBM5) in the CNS—moving beyond cancer to harness RNA splicing to mitigate the consequences of brain injury. Front Mol Neurosci, 2020; 13; doi:10.3389/fnmol.2020.00126
12.
Lopez-RodriguezAB, Acaz-FonsecaE, ViverosMP, et al.Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit. PLoS One, 2015; 10(6):e0128782, doi:10.1371/journal.pone.0128782
13.
FournierML, ClémentT, AussudreJ, et al.Contusion rodent model of traumatic brain injury: controlled cortical impact. Methods Mol Biol (Clifton, NJ), 2021; 2193:49–65; doi:10.1007/978-1-0716-0845-6_6
14.
SieboldL, ObenausA, GoyalR. Criteria to define mild, moderate, and severe traumatic brain injury in the mouse controlled cortical impact model. Exp Neurol, 2018; 310:48–47; doi:10.1016/j.expneurol.2018.07.004
15.
CaoF, JiangY, WuY, et al.Apolipoprotein E-Mimetic COG1410 reduces acute vasogenic edema following traumatic brain injury. J Neurotrauma, 2016; 33(2):175–182; doi:10.1089/neu.2015.3887
16.
MehmoodA, LaihoA, VenäläinenMS, et al.Systematic evaluation of differential splicing tools for RNA-seq studies. Briefings Bioinformat, 2020; 21(6):2052–2065; doi:10.1093/bib/bbz126
17.
ShenS, ParkJW, HuangJ, et al.MATS: a Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data. Nucleic Acids Res, 2012; 40(8):e61; doi:10.1093/nar/gkr1291
18.
KerenH, Lev-MaorG, AstG. Alternative splicing and evolution: diversification, exon definition and function. Nat Rev Genet, 2010; 11(5):345–355; doi:10.1038/nrg2776
19.
LiS, TaoW, HuangZ, et al.The Transcriptional landscapes and key genes in brain arteriovenous malformation progression in a venous hypertension rat model revealed by RNA sequencing. J Inflam Res, 2022; Volume 15:1381–1397; doi:10.2147/jir.s347754
20.
VolbersB, StaykovD, WagnerI, et al.Semi-automatic volumetric assessment of perihemorrhagic edema with computed tomography. European J Neurol, 2011; 18(11):1323–1328; doi:10.1111/j.1468-1331.2011.03395.x
BarbetG, DemionM, MouraIC, et al.The calcium-activated nonselective cation channel TRPM4 is essential for the migration but not the maturation of dendritic cells. Nat Immunol, 2008; 9(10):1148–1156; doi:10.1038/ni.1648
23.
SharmaHS, MiclescuA, WiklundL. Cardiac arrest-induced regional blood-brain barrier breakdown, edema formation and brain pathology: a light and electron microscopic study on a new model for neurodegeneration and neuroprotection in porcine brain. J Neural Transmission (Vienna, Austria: 1996), 2011; 118(1):87–114; doi:10.1007/s00702-010-0486-4
24.
LiaoJ-Y, YangB, ZhangY-C, et al.EuRBPDB: a comprehensive resource for annotation, functional and oncological investigation of eukaryotic RNA binding proteins (RBPs). Nucleic Acids Res, 2020; 48(D1):D307–D313; doi:10.1093/nar/gkz823
25.
WooSK, TsymbalyukN, TsymbalyukO, et al.SUR1-TRPM4 channels, not KATP, mediate brain swelling following cerebral ischemia. Neurosci Lett, 2020; 718; doi:10.1016/j.neulet.2019.134729
26.
BarzóP, MarmarouA, FatourosP, et al.Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. J Neurosury, 1997; 87(6):900–907; doi:10.3171/jns.1997.87.6.0900
27.
JhaRM, KochanekPM, SimardJM. Pathophysiology and treatment of cerebral edema in traumatic brain injury. Neuropharmacology, 2019; 145:230–246,;doi:10.1016/j.neuropharm.2018.08.004
28.
JinY, DongH, ShiY, et al.Mutually exclusive alternative splicing of pre-mRNAs. Wiley Interdisciplinary Reviews RNA, 2018; 9(3):e1468; doi:10.1002/wrna.1468
29.
EarleyS, WaldronBJ, BraydenJE. Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res, 2004; 95(9):922–929; doi:10.1161/01.res.0000147311.54833.03
30.
MatharI, JacobsG, KecskesM, et al.Trpm4. In: Mammalian Transient Receptor Potential (TRP) Cation Channels. 2014; pp. 461–487
31.
GerzanichV, WooSK, VennekensR, et al.De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury. Nat Med, 2009; 15(2):185–191; doi:10.1038/nm.1899
32.
VennekensR, OlaussonJ, MeissnerM, et al.Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. Nat Immunol, 2007; 8(3):312–320; doi:10.1038/ni1441
33.
WangC, ChenJ, WangM, et al.Role of the TRPM4 channel in mitochondrial function, calcium release, and ROS generation in oxidative stress. Biochem Biophys Res Commun, 2021; 566:190–196; doi:10.1016/j.bbrc.2021.03.077
34.
YooJC, YarishkinOV, HwangEM, et al.Cloning and characterization of rat transient receptor potential-melastatin 4 (TRPM4). Biochem Biophys Res Commun, 2010; 391(1):806–811; doi:10.1016/j.bbrc.2009.11.142
35.
CederholmJME, KimY, von JonquieresG, et al.Human brain region-specific alternative splicing of TRPC3, the type 3 canonical transient receptor potential non-selective cation channel. Cerebellum (London, England), 2019; 18(3):536–543; doi:10.1007/s12311-019-01026-4
36.
WinklerEA, MinterD, YueJK, et al.Cerebral edema in traumatic brain injury: pathophysiology and prospective therapeutic targets. Neurosurg Cli North Am, 2016; 27(4):473–488,;doi:10.1016/j.nec.2016.05.008
37.
del ZoppoGJ. The neurovascular unit in the setting of stroke. J Intern Med, 2010; 267(2):156–171; doi:10.1111/j.1365-2796.2009.02199.x
38.
MracskoE, VeltkampR. Neuroinflammation after intracerebral hemorrhage. Front Cell Neurosci, 2014; 8388, doi:10.3389/fncel.2014.00388
39.
OhnishiM, KatsukiH, FukutomiC, et al.HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats. Neuropharmacology, 2011; 61(5-6):975-80, doi:10.1016/j.neuropharm.2011.06.026
BocheD, PerryVH, NicollJA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol, 2013; 39(1):3–18; doi:10.1111/nan.12011
ZamanianJL, XuL, FooLC, et al.Genomic analysis of reactive astrogliosis. J Neuroscience, 2012; 32(18):6391–6410; doi:10.1523/JNEUROSCI.6221-11.2012
44.
TurnerRJ, SharpFR. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front Cell Neurosci, 2016; 10:56; doi:10.3389/fncel.2016.00056
45.
GerzanichV, KwonMS, WooSK, et al.SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells. PLoS One, 2018; 13(4):e0195526; doi:10.1371/journal.pone.0195526
46.
LeeJY, ChoiHY, NaWH, et al.Ghrelin inhibits BSCB disruption/hemorrhage by attenuating MMP-9 and SUR1/TrpM4 expression and activation after spinal cord injury. Biochimica et biophysica acta, 2014; 1842(12 Pt A):2403–2412; doi:10.1016/j.bbadis.2014.09.006
47.
JiangB, LiL, ChenQ, et al.Role of glibenclamide in brain injury after intracerebral hemorrhage. Trans Stroke Res, 2017; 8(2):183–193; doi:10.1007/s12975-016-0506-2
48.
WolburgH, NoellS, Fallier-BeckerP, et al.The disturbed blood–brain barrier in human glioblastoma. Mol Aspects Med, 2012; 33(5-6):579–589; doi:10.1016/j.mam.2012.02.003
49.
StokumJA, KwonMS, WooSK, et al.SUR1-TRPM4 and AQP4 form a heteromultimeric complex that amplifies ion/water osmotic coupling and drives astrocyte swelling. Glia, 2018; 66(1):108–125; doi:10.1002/glia.23231
50.
YangSY, LejaultP, ChevrierS, et al.Transcriptome-wide identification of transient RNA G-quadruplexes in human cells. Nat Commun, 2018; 9(1):4730; doi:10.1038/s41467-018-07224-8
51.
KharelP, BalaratnamS, BealsN, et al.The role of RNA G-quadruplexes in human diseases and therapeutic strategies. Wiley Interdisciplinary Reviews RNA, 2020; 11(1):e1568; doi:10.1002/wrna.1568
52.
ConlonEG, LuL, SharmaA, et al.The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. eLife, 2016; 5; doi:10.7554/eLife.17820
53.
DonnellyCJ, ZhangPW, PhamJT, et al.RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron, 2013; 80(2):415–428; doi:10.1016/j.neuron.2013.10.015
54.
ZhangJ, HarveySE, ChengC. A high-throughput screen identifies small molecule modulators of alternative splicing by targeting RNA G-quadruplexes. Nucleic Acids Res, 2019; 47(7):3667–3679; doi:10.1093/nar/gkz036
55.
JhaRM, BellJ, CiterioG, et al.Role of sulfonylurea receptor 1 and glibenclamide in traumatic brain injury: a review of the evidence. Int J Mol Sci, 2020; 21(2); doi:10.3390/ijms21020409
56.
GorseKM, LantzyMK, LeeED, et al.Transient receptor potential melastatin 4 induces astrocyte swelling but not death after diffuse traumatic brain injury. J Neurotrauma, 2018; 35(14):1694–1704; doi:10.1089/neu.2017.5275
57.
JhaRM, DesaiSM, ZusmanBE, et al.Downstream TRPM4 polymorphisms are associated with intracranial hypertension and statistically interact with ABCC8 polymorphisms in a prospective cohort of severe traumatic brain injury. J Neurotrauma, 2019; 36(11):1804–1817; doi:10.1089/neu.2018.6124
58.
Aartsma-RusA, Van DeutekomJC, FokkemaIF, et al.Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle & nerve, 2006; 34(2):135–144; doi:10.1002/mus.20586
59.
Aartsma-RusA, FokkemaI, VerschuurenJ, et al.Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Human Mutation, 2009; 30(3):293–299; doi:10.1002/humu.20918
60.
DhillonS. Viltolarsen: First Approval. Drugs, 2020; 80(10):1027–1031; doi:10.1007/s40265-020-01339-3
61.
DietrichJB. The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J Neuroimmunol, 2002; 128(1-2):58–68; doi:10.1016/s0165-5728(02)00114-5
62.
MaQ, WangC, WangM, et al.Investigation of brain damage mechanism in middle cerebral artery occlusion/reperfusion rats based on i-TRAQ quantitative proteomics. Experimental brain research, 2021; 239(4):1247–1260; doi:10.1007/s00221-021-06054-3
63.
ShinH, LeeJ, KimY, et al.Knockdown of BC200 RNA expression reduces cell migration and invasion by destabilizing mRNA for calcium-binding protein S100A11. RNA Biol, 2017; 14(10):1418–1430; doi:10.1080/15476286.2017.1297913
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
